The article CME Amsterdam B.V. receives approval from Dutch Minister of Finance appeared on FinanceFeeds.
The establishment of the new Amsterdam-based thing will guarantee that CME Group’s BrokerTec and EBS places and CME Regulatory Reporting services (formerly called NEX Regulatory Reporting) may continue to support their European Union clients, regardless of the results of this UK’s withdrawal from the EU.
CME Group will transition the next companies to CME Amsterdam B.V. – BrokerTec’s European Government Bond and European Repo businesses (under a new Regulated Market licence) and on-MTF FX forward and swaps (below a new MTF licence), to keep a single pool of bandwidth. BrokerTec’s UK Gilts and Gilt Repo companies and all other EBS companies, will continue to function with no change.
CME today announces that its legal thing CME Amsterdam B.V. has secured approval from the Dutch Minister of Finance.
CME Amsterdam B.V. will operate alongside Abide Financial DRSP Limited (AFDL), that is authorised as an ARM and APA by the UK FCA and certainly will continue to provide these services to UK customers.
CME Amsterdam B.V. has been set to initiate operations in March 18, 2019.
What’s more, CME Group will transition the CME Regulatory Reporting Approved Novel Deal (APA) and Approved Reporting Mechanism (ARM) commerce and trade reporting services for EU27 customers to CME Amsterdam B.V., in order to minimise disturbance and assist clients in fulfilling their MiFID II responsibilities.
International derivatives market CME Group Inc (NASDAQ:CME) is actively preparing for several possible results of their UK’s withdrawal from the European Union. The Group has only marked a significant accomplishment in this respect.